What is the appropriate treatment for bacterial vaginosis?

Treatment of Bacterial Vaginosis

For non-pregnant women with bacterial vaginosis, treat with metronidazole 500 mg orally twice daily for 7 days, which is the most effective first-line regimen. 1

First-Line Treatment Options (Equally Recommended)

The CDC guidelines provide three equally recommended regimens for non-pregnant women: 1

• Metronidazole 500 mg orally twice daily for 7 days (preferred for efficacy)
• Metronidazole gel 0.75%, one full applicator (5g) intravaginally once daily for 5 days
• Clindamycin cream 2%, one full applicator (5g) intravaginally at bedtime for 7 days (note: less efficacious than metronidazole regimens) 1

Important counseling points: Patients must avoid alcohol during metronidazole treatment and for 24 hours after completion to prevent disulfiram-like reactions. 1 Clindamycin cream is oil-based and weakens latex condoms and diaphragms. 1

Alternative Regimens (Lower Efficacy)

Use these only when first-line options are not feasible: 1

• Metronidazole 2g orally as a single dose (lower cure rate)
• Clindamycin 300 mg orally twice daily for 7 days
• Clindamycin ovules 100g intravaginally once at bedtime for 3 days

Special Populations

Pregnant Women

All symptomatic pregnant women must be tested and treated because BV is associated with serious adverse outcomes including premature rupture of membranes, preterm labor, preterm birth, postpartum endometritis, and post-cesarean wound infections. 1

Recommended regimens for pregnancy: 1

• Metronidazole 250 mg orally three times daily for 7 days, OR
• Clindamycin 300 mg orally twice daily for 7 days

Critical point: Use systemic (oral) therapy only in pregnancy—topical agents are not recommended. 1 Evidence from three trials shows increased adverse events (prematurity and neonatal infections) after clindamycin cream use during pregnancy. 1 Multiple studies confirm metronidazole has no consistent association with teratogenic or mutagenic effects. 1

High-risk pregnant women (those with prior preterm delivery) who have asymptomatic BV should be evaluated for treatment, as three of four randomized trials showed reduced preterm delivery with treatment. 1

Allergy or Intolerance

• If allergic to metronidazole: use clindamycin cream or oral clindamycin 1
• If intolerant to systemic metronidazole: metronidazole gel may be considered 1
• Never give metronidazole gel to patients allergic to oral metronidazole 1

Recurrent Bacterial Vaginosis

Recurrence occurs in 50-80% of women within one year after antibiotic treatment. 2, 3 For recurrent cases: 3

• Extended metronidazole 500 mg twice daily for 10-14 days as first approach
• If ineffective: metronidazole gel 0.75% for 10 days, then twice weekly for 3-6 months 3

Groundbreaking new evidence (2025): A landmark randomized controlled trial demonstrated that treating male partners significantly reduces BV recurrence. 4 When male partners received combined oral metronidazole 400 mg and topical 2% clindamycin cream (both twice daily for 7 days) along with standard female treatment, recurrence dropped from 63% to 35% at 12 weeks (absolute risk reduction of 2.6 recurrences per person-year, P<0.001). 4 This trial was stopped early due to clear superiority of partner treatment. 4

Partner treatment should now be considered for women in monogamous relationships with male partners to prevent recurrence. 4, 5

Management Considerations

Partner treatment: Historically, routine treatment of sex partners was not recommended based on older trials. 1 However, the 2025 StepUp trial provides strong evidence that male-partner treatment prevents recurrence. 4, 5

Follow-up: Unnecessary if symptoms resolve, but women should return if symptoms recur. 1 No long-term maintenance regimen is recommended for standard cases. 1

Probiotics: Vaginal products containing Lactobacillus crispatus show promise for recurrent BV prevention, though more research is needed. 6, 2 Non-vaginal lactobacilli and douching are not supported by evidence. 1

Pre-Procedural Prophylaxis

Screen and treat BV before surgical abortion or hysterectomy, as treatment with metronidazole reduces post-operative infectious complications by 10-75%. 1 This is in addition to routine prophylaxis. 1